Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 12NIH 4NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 39Other hematologic neoplasm 25Sarcoma 23CNS 23Gynecologic 14Genitourinary 12Breast 9Thoracic 5Plasma cell 5Gastrointestinal 3Endocrine 3Dermatologic 3Myeloid 2Head & Neck 2Classical hematology 2Other solid neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2

Interventions

Cisplatin 53Radiotherapy 36Fluorouracil 16Paclitaxel 15Radiotherapy, Intensity-Modulated 14Docetaxel 12Cetuximab 12Carboplatin 12Platinum 6Immunohistochemistry 6Radiotherapy, Conformal 5Gene Expression Profiling 5Radiation 4Polymerase Chain Reaction 4Nimorazole 4Drug Therapy 4Chemotherapy, Adjuvant 41,2-diaminocyclohexaneplatinum II citrate 4durvalumab 3Taxes 3Magnetic Resonance Spectroscopy 3In Situ Hybridization, Fluorescence 3Gemcitabine 3Afatinib 3vandetanib 2pembrolizumab 2dehydroftorafur 2Surgical Procedures, Operative 2Specimen Handling 2Reverse Transcriptase Polymerase Chain Reaction 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Filgrastim × Head & Neck × Clear all
NCT00005087 2015-11-17

Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 2 Completed
105 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00113399 2013-07-02

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Radiation Therapy Oncology Group

Phase 3 Terminated
15 enrolled 5 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡